Kelly Colletti obtained her PhD in Cellular and Molecular Biology as well as her MBA at the University of Nevada, Reno in 2005. She is a trained herpes virologist that studied the molecular mechanisms of Cytomegalovirus and Karposi’s Sarcoma Associated Herpes Virus DNA replication. Kelly joined Charles River in early 2009 and is currently the Scientific Director of Bioanalytical and Molecular Biology. During her tenure at Charles River, she has developed and validated hundreds of bioanalytical methods including nonclinical and clinical bioanalytical, immunogenicity, nAb, qPCR, and biomarker assays. Kelly has participated in over 15 biosimilar programs validating bioanalytical and immunogenicity assays to support nonclinical and clinical studies and has supported several BLA filings. She has substantial expertise in the area of Bioanalysis of antibody-drug conjugates and bi-specific antibodies as well as gene and cell therapy.
Kelly Colletti, PhD, MBA